Insights Hub

All content

• 

  Healthcare Publication

  Why Oncologists Are Prescribing GLP-1s

  When cancer specialists embrace – and when they avoid – this revolutionary drug class.

  08.07.26
• 

  Infrastructure Survey

  Continued appetite for investment in infrastructure alongside pragmatism to improve outcomes

  The 2026 Global Infrastructure Index from Ipsos and the Global Infrastructure Investor Association (GIIA).

  07.07.26
• 

  Healthcare Publication

  Beyond the Step Change: What GLP-1s Solved - and What They Didn’t

  GLP-1 therapies have redefined what obesity pharmacotherapy can achieve, but efficacy is no longer the only battleground.

  06.07.26
• 

  Energy Survey

  The Ipsos Energy Transition Barometer

  In the 2026 Energy Transition Barometer, we look at how affordability, security, and reliability concerns are converging to reshape public support for the energy transition across 31 countries — including a rare before-and-after view of attitudes following the Iran conflict.

  02.07.26
• 

  Sports Publication

  Ipsos Update – July 2026

  Football, Pride, Digital Twins… Ipsos Update explores the latest research and thinking on key topics from Ipsos teams around the world.

  01.07.26

• Preference Center

  Manage your communication preferences from Ipsos

  Update

• 

  Politics Survey

  Know the New America & Beyond: June 2026

  A monthly dispatch of Ipsos’ best insights on the U.S., tailored for the world

  25.06.26
• 

  What Worries the World Survey

  What Worries the World – June 2026

  Conducted monthly in 30 countries among around 20,000 adults for over a decade, the Ipsos What Worries the World study offers an exceptional snapshot of world opinion on pressing global issues.

  25.06.26
• 

  Consumer Confidence Index Survey

  June 2026: Global consumer confidence shows uptick for second consecutive month

  Sentiment in Europe rises significantly according to the June 2026 Global Consumer Confidence Index from Ipsos.

  24.06.26
• 

  Healthcare Publication

  Beyond the Claim: The Case for Direct-to-Responder RWE in U.S. Healthcare

  The U.S. healthcare claims system is a reputable source of secondary real-world data, but what happens when the patient falls out of the system?

  24.06.26
• 

  Sexuality Survey

  Ipsos Pride Report 2026

  Our 2026 edition of the Ipsos LGBT+ Pride report shows attitudes stabilising across 26 countries on several key measures, including trans athletes and LGBT media representation.

  23.06.26
• 

  Luxury Publication

  Ipsos Global Influentials

  Explore Ipsos Global Influentials (IGI) infographics and survey insights on how the world's wealthiest consumers and company leaders think, spend, and engage.

  22.06.26